Putnam Investments LLC Mirati Therapeutics, Inc. Transaction History

Putnam Investments LLC

$73 Billion
Q4 2023

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$132.13 - $177.45 $7.56 Million - $10.2 Million	-57,200 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$144.0 - $179.73 $3.36 Million - $4.2 Million	23,344 Added 68.95%	57,200 $9.24 Million
Q1 2021 May 17, 2021	SELL	$158.92 - $221.61 $171,156 - $238,673	-1,077 Reduced 3.08%	33,856 $5.8 Million
Q4 2020 Feb 16, 2021	SELL	$162.05 - $240.27 $203,858 - $302,259	-1,258 Reduced 3.48%	34,933 $7.67 Million
Q3 2020 Nov 16, 2020	SELL	$113.26 - $167.27 $4,643 - $6,858	-41 Reduced 0.11%	36,191 $6.01 Million
Q2 2020 Aug 14, 2020	SELL	$72.01 - $120.39 $10.7 Million - $17.9 Million	-149,054 Reduced 80.45%	36,232 $4.14 Million
Q1 2020 May 15, 2020	BUY	$69.78 - $116.21 $10.5 Million - $17.6 Million	151,115 Added 442.23%	185,286 $14.2 Million
Q4 2019 Feb 14, 2020	SELL	$70.76 - $128.86 $3.07 Million - $5.59 Million	-43,386 Reduced 55.94%	34,171 $4.4 Million
Q3 2019 Nov 14, 2019	BUY	$77.91 - $109.6 $1.65 Million - $2.32 Million	21,197 Added 37.61%	77,557 $6.04 Million
Q2 2019 Aug 14, 2019	SELL	$59.49 - $104.71 $5.68 Million - $9.99 Million	-95,451 Reduced 62.87%	56,360 $5.81 Million
Q1 2019 May 15, 2019	SELL	$43.65 - $78.95 $12.4 Million - $22.5 Million	-284,688 Reduced 65.22%	151,811 $11.1 Million
Q4 2018 Feb 14, 2019	BUY	$32.0 - $47.43 $12.2 Million - $18.1 Million	382,051 Added 701.68%	436,499 $18.5 Million
Q3 2018 Nov 14, 2018	BUY	$47.1 - $62.7 $1.48 Million - $1.97 Million	31,490 Added 137.16%	54,448 $2.56 Million
Q2 2018 Aug 14, 2018	SELL	$26.05 - $52.4 $17.5 Million - $35.1 Million	-670,609 Reduced 96.69%	22,958 $1.13 Million
Q1 2018 May 15, 2018	SELL	$17.2 - $34.95 $4.23 Million - $8.6 Million	-246,041 Reduced 26.19%	693,567 $21.3 Million
Q4 2017 Feb 14, 2018	BUY	$12.65 - $19.0 $11.9 Million - $17.9 Million	939,608	939,608 $17.1 Million

Others Institutions Holding MRTX

# of Institutions

Shares Held

3.57M

Call Options Held

Put Options Held

36.6K

View Full List

About Mirati Therapeutics, Inc.

Ticker MRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,609,800
Description
Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase 1/2 clinical trial for treating non-small cell lung (NSCL), colorectal, pancreatic, and other cancers; ...

More about MRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Putnam Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Putnam Investments LLC with notifications on news.

Account